Finally, ginsenoside liposomes changed the immune-deficiency TME, mainly through reducing the heterogeneous cells in the TME and enhancing the immune function by increasing the infiltration of the CD8+ T cells. The gene discussed is CD8A; the disease is Immunodeficiency.